DYNAMICS OF ADDICTION

BENNYROSE D. ARNECILLA, PhD, MPA, RSW

Chief Probation Officer
PPA-DOJ Calabarzon Region

1
 Dynamics of Addiction

Skills
Attitude
Knowledge
Personal Communication
 Training/s
- RA9165
- RA 10630
orientation/ Interpersonal
- Other related values Cooperation
laws on children
 MSWDO
- Intervention
- Approaches VMGs, Core Collaboration
 Work experience,
etc Values Coordination
Ethics
Dynamics of Addiction

Person-in -environment
 Addiction is a Developmental problem:
It Starts Early
100
67%

26%

10
5.5%

1.5%

1
Child<12 Teen 12-17 Young Adult 18-25 Adult >25

Prevention efforts are therefore of primary importance -

to address addiction before it ever starts.
Why Teens Take Drugs?

 BOREDOM
 PEER PRESSURE
 CURIOSITY

 FORGET PROBLEMS

 CONTROL HUNGER PANGS

Young Adults Fertility and Sexuality Survey 3,
(YAFSS)2002 University of the Phil. –Population Institute

•11% have tried illicit drugs

•46% have tried smoking
•70% have tried drinking

SOCIETY OF ADOLESCENT MEDICINE OF THE PHIL (SAMPI)

Behavioral Changes in Adolescent
Drug Users

• Changes in school performance

• Changes in peer group
• Breaking rules at home, school, in the community
• Extreme mood swings, depression, irritability, anger,
negative attitude
• Sudden increases or decreases in activity level
• Withdrawal from the family; keeping secrets
Behavioral Changes in Adolescent
Drug Users
• Changes in physical appearance
• Red, watery, glassy eyes or runny nose not due to
allergies or cold
• Changes in eating or sleeping habits
• Lack of motivation or interest in things other
teenagers enjoy
• Lying, stealing, hiding things
• Using street or drug language or possession of drug
paraphernalia or items
I. Definition of Terms
I. Definition of Terms
II. Common Reasons Cited for
Substance Abuse and Dependence
II. Common Reasons Cited for
Substance Abuse and Dependence
III. Addiction is not just a
Psycho-social problem.
IV. Addiction: It is a Brain Disease
UNDERSTANDING ADDICTION
V. Drug Stage Continuum

• STAGE I: EXPERIMENTAL USE

• STAGE II: SEEKING THE MOOD SWING / OCCASIONAL USE

• STAGE III: HARMFUL / INTENSIFIED USE

• STAGE IV: DEPENDENCE

VI. Common Substances of Abuse
PSYCHOLOGICAL EFFECTS: PHYSICAL EFFECTS:

a single joint of MJ = smoking 15 cigarettes

Marijuana
INTERMEDIATE effects LONG TERM effects
• hallucinations/ illusions. • renal damage, heart
• bloodshot eye, REM disease, stroke.
• faster heart rate, and pulse rate. • psychiatric consequences.
• dry mouth and throat • severe irritation of nasal
• forgetfulness/ inability to think. passage.
• “food trip” & sleepiness
• disorientation
MARIJUANA
EUPHORIANT effect of cannabis has been known for thousand of years.

HIGH dose – HALLUCINATION, DELUSION & PARANOID IDEATIONS

HIGHER dose – PSYCHOSIS w/ hallucination, DEPERSONALIZATION &
LOSS OF INSIGHT
FLASHBACKS – persisting perceptual abnormalities after cannabis use

AMOTIVATIONAL SYNDROME - associated with long term heavy use of

marijuana & has been characterized by an individual’s unwillingness
to persist in a task.
SHORT TERM
• loss of appetite
• euphoria, elation
• inability to sleep
• tension, anxiety
• irritability, loss of self
control
• irrational behavior
Methamphetamine HCl
(SHABU)
MODERATE DOSE given to a normal subject
• Increases sense of well being
• Induces elation/ euphoria, friendliness
• Decreases fatigue
• Increases performance in written, oral and
performed tasks
• Induction of anorexia
• Heightening of pain threshold
LONG TERM

• full-blown psychosis
or schizophrenia
• paranoia
Inhalants
Inhalants
•Malnutrition

•Retardation

•Skin rashes
Alcohol
Nicotine and other chemicals
Cigarettes
Nicotine and other chemicals
Cigarettes




 Treatment Can Work!
• No single treatment is appropriate for all individuals.

• Treatment needs to be readily available.

• Treatment must attend to multiple needs of the individual, not just

drug use.

• Multiple courses of treatment may be required for success.

• Remaining in treatment for an adequate period of time is critical

for treatment effectiveness.
 MARAMING SALAMAT PO

BENNYROSE D. ARNECILLA, PhD, MPA, RSW

Chief Probation Officer
PPA-DOJ Calabarzon Region